EBAG9 and cancer: In different human cancers, the expression of the estrogen-responsive gene RCAS1 has been correlated to clinical outcomes in ovarian cancer and to the survival rate in patients suffering from uterine and cervical adenocarcinoma, as well as esophageal, pancreatic, lung, gallbladder, and pancreatic cancers.